Toroso Investments, LLC Vir Biotechnology, Inc. Transaction History

Toroso Investments, LLC

  • $8.31 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$7.63 - $12.66 $38,111 - $63,236
-4,995 Reduced 14.37%
29,755 $264,000
Q1 2024

May 15, 2024
BUY
$8.6 - $11.9 $298,850 - $413,525
34,750 New
34,750 $352,000
Q1 2023

May 15, 2023
BUY
$22.26 - $30.85 $445,533 - $617,462
20,015 New
20,015 $466,000

Others Institutions Holding VIR

# of Institutions
218
Shares Held
87.1M
Call Options Held
165K
Put Options Held
1.23M
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $1.21B
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Toroso Investments, LLC Portfolio

Follow Toroso Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toroso Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Toroso Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email